Cytek BioSciences, Inc. (CTKB): Price and Financial Metrics

Cytek BioSciences, Inc. (CTKB): $5.11

0.16 (+3.23%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

CTKB Price/Volume Stats

Current price $5.11 52-week high $9.87
Prev. close $4.95 52-week low $3.80
Day low $4.95 Volume 824,200
Day high $5.23 Avg. volume 669,179
50-day MA $5.21 Dividend yield N/A
200-day MA $6.23 Market Cap 672.00M

CTKB Stock Price Chart Interactive Chart >


Cytek BioSciences, Inc. (CTKB) Company Bio


Cytek Biosciences, Inc. engages in the manufacture and sale of cell analysis solutions for clinical and biomedical research in the fields of drug discovery, genomics, immuno-oncology, immuno-profiling, infectious diseases, inflammatory diseases, and multi-site standardization applications. Its instruments include the Aurora and Northern Lights systems, which are flow cytometers to deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also offers cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. Its customers include pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. Cytek Biosciences, Inc. was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. The company was incorporated in 2014 and is headquartered in Fremont, California.


CTKB Latest News Stream


Event/Time News Detail
Loading, please wait...

CTKB Latest Social Stream


Loading social stream, please wait...

View Full CTKB Social Stream

CTKB Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!